Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Brain scans show that most of us have a built-in capacity to learn to code, rooted in the brain’s logic and reasoning ...

Global silicon wafer shipments are projected to rebound 5.4%, rising from 12,165 million square inches (MSI) in 2024 to 12,824 MSI, according to the latest forecast from SEMI. The association ...

Abstract: An intrusion detection system (IDS) plays a crucial role in network security by distinguishing hostile activities from network traffic. Conventional hardware-based IDS architectures have ...

Elitecon International share price hit a 5 per cent upper circuit on Wednesday. The multibagger stock has been hitting the upper circuit for four consecutive sessions. At 1:10 pm, the Elitecon ...

A more conservative Third Circuit debuted at en banc arguments, as two new appointees of President Donald Trump heard their first case. Judges Emil Bove and Jennifer Mascott joined other members of ...

HONG KONG, Oct 13 (Reuters Breakingviews) - The truce between the United States and China always looked too good to last. What's surprising is how quickly it has fallen apart. The world's two largest ...

Here is a list of local businesses offering free food to people losing SNAP benefits Several businesses are offering help to people slated to lose SNAP benefits due to the federal government shutdown.

The third “Tron” movie continues the saga begun over four decades ago, and now, the programs are in our world. By Alissa Wilkinson When you purchase a ticket for an independently reviewed film through ...

The shares of Eimco Elecon (India) jumped 20 percent to hit the upper circuit on October 8 after ace investor Vijay Kedia bought stake worth nearly Rs 11 crore in the company. According to the latest ...

Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to restore immune homeostasis. The New York-headquartered company was founded by a ...

Having closed a nine-figure fundraising round, a newly launched biotechnology company hopes to rewire the immune system with drugs aimed at a special kind of nerve cell. Nilo Therapeutics debuted ...